SCHEMBL7651566

SCHEMBL7651566

CCOC(=O)Cc1cccnc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 3/20 0.48
MAPT P10636 3/20 0.47
MAPK1 P28482 3/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
TBXAS1 P24557 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 1/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ATM Q13315 1/20 0.45
PKM P14618 1/20 0.45
SLC2A2 P11168 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11253180 0.83 GAA (0.49) SMN1; SMN2LMNAMAPTMAPK1TRPM8
SCHEMBL3595140 0.80 MAPT (0.48) SMN1; SMN2LMNAMAPTMAPK1ALDH1A1
SCHEMBL7651562 0.80 MAPT (0.53) SMN1; SMN2LMNAMAPTMAPK1TRPM8
SCHEMBL11499255 0.80 GAA (0.46) SMN1; SMN2LMNAMAPTTRPM8MEN1
SCHEMBL8491910 0.80 KDM4E (0.59) LMNAMAPTALDH1A1KDM4ETDP1
SCHEMBL29852705 0.79 MAPT (0.64) SMN1; SMN2LMNAMAPTMAPK1ALDH1A1
Ammonia Solution, Strong SCHEMBL27803914 0.78 MAPT (0.48) LMNAMAPTMAPK1TRPM8MEN1
SCHEMBL4193609 0.78 MAPK1 (0.49) SMN1; SMN2LMNAMAPTMAPK1TRPM8
SCHEMBL13869175 0.78 PTGS1 (0.46) MAPTALDH1A1KDM4ETDP1HSD17B10
SCHEMBL21973538 0.78 PTGS1 (0.46) MAPTALDH1A1KDM4ETDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed